National Health Valuation
| WX6 Stock | EUR 60.00 0.50 0.83% |
At this time, the firm appears to be undervalued. National Health Investors secures a last-minute Real Value of €68.64 per share. The latest price of the firm is €60.0. Our model forecasts the value of National Health Investors from analyzing the firm fundamentals such as Return On Equity of 0.0467, current valuation of 3.32 B, and Profit Margin of 0.24 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend locking in undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Undervalued
Today
Please note that National Health's price fluctuation is very steady at this time. Calculation of the real value of National Health Investors is based on 3 months time horizon. Increasing National Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for National Health Investors is useful when determining the fair value of the National stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of National Health. Since National Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of National Stock. However, National Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 60.0 | Real 68.64 | Hype 60.5 | Naive 59.46 |
The real value of National Stock, also known as its intrinsic value, is the underlying worth of National Health Investors Company, which is reflected in its stock price. It is based on National Health's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of National Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence National Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of National Health Investors helps investors to forecast how National stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of National Health more accurately as focusing exclusively on National Health's fundamentals will not take into account other important factors: National Health Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining National Health's current stock value. Our valuation model uses many indicators to compare National Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across National Health competition to find correlations between indicators driving National Health's intrinsic value. More Info.National Health Investors is rated first in price to earning category among related companies. It is rated second in price to book category among related companies fabricating about 0.09 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for National Health Investors is roughly 10.67 . Comparative valuation analysis is a catch-all model that can be used if you cannot value National Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for National Health's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the National Health's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates National Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in National Health and how it compares across the competition.
About National Health Valuation
The stock valuation mechanism determines the current worth of National Health Investors on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of National Health Investors. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of National Health Investors based exclusively on its fundamental and basic technical indicators. By analyzing National Health's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of National Health's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of National Health. We calculate exposure to National Health's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to National Health's related companies.is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHIs portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. NATL HEALTH operates under REIT - Healthcare Facilities classification in Germany and is traded on Frankfurt Stock Exchange. It employs 16 people.
8 Steps to conduct National Health's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates National Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct National Health's valuation analysis, follow these 8 steps:- Gather financial information: Obtain National Health's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine National Health's revenue streams: Identify National Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research National Health's industry and market trends, including the size of the market, growth rate, and competition.
- Establish National Health's growth potential: Evaluate National Health's management, business model, and growth potential.
- Determine National Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate National Health's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for National Stock analysis
When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |